Table 1:
Article | Year | Journal | Study Type | rtPA Dose/NINDS | Site of Occlusion | Recan. Assessment Tool | Recan. Times | No. of Patients With Recan. | Total No. of Relevant Patients |
---|---|---|---|---|---|---|---|---|---|
Noncontrast Studiesb | |||||||||
Alexandrov et al | 2004 | Stroke | Prospective cohort | Yes <180 min | M1, M2 | TCD | 2 h (Post-rtPA) | 73 | 120 |
Daffertshofer et al | 2005 | Stroke | NRCT | Yes <360 min | ICA, M1, M2, M3 | MRA | 24 h | 10 | 26 |
Derex at al | 2004 | Neuroradiology | Prospective cohort | No <360 min | ICA, M1, M2, ACA | MRA | 24 h | 28 | 47 |
Eggers at al | 2003 | Ann Neurol | RCT | Yes <180 min | M1, M2 | TCD | 1 h (Post-rtPA) | 8 | 25 |
Gerriets et al | 2002 | Stroke | RCT (substudy of DIAS 1) | Yes <360 min | ICA, M1, M2 | TCD | 24 h | 8 | 11 |
Kwon et al | 2004 | Arch Neurol | Retrospective cohort | Yes <360 min | ICA, MCA | MRA | 72 h | 14 | 20 |
Molina et al | 2001 | Stroke | Case control | Yes <180 min | M1, M2 | TCD | 48 h | 22 | 24 |
Neumann-Haefelin et al | 2004 | Stroke | Retrospective cohort | NS <360 min | M1 | MRA | 24 h | 18 | 52 |
Rubiera et al | 2006 | Stroke | Prospective cohort | Yes <360 min | ICA, M1, M2 | TCD | 2 h (Post-rtPA) | 141 | 219 |
Savitz et al | 2005 | Stroke | Retrospective cohort | Yes <360 min | ICA, MCA | MRA | 72 h | 27 | 37 |
Sekoranja et al | 2006 | Stroke | Prospective cohort | Yes <180 min | ICA, MCA | TCD | 30 min (Post-rtPA) | 17 | 33 |
Yasaka et al | 1998 | Neurology | RCT | No 210 ± 36 min | MCA; origin, trunk, distal | TCD | 24 h | 8 | 8 |
Contrast Contrast studiesb | |||||||||
Muir et al | 2005 | JNNP | Prospective cohort | Yes <200 min | M1, M2 | CTA, TCD, DSA | 48 h | 9 | 12 |
Murphy et al | 2006 | Stroke | Prospective cohort | NS <420 min | MCA syndrome | CTA | 24 h | 4 | 7 |
Wintermark et al | 2006 | Stroke | Prospective cohort | No <420 min | Large-artery occlusion | MRA | 2–7 d | 28 | 41 |
von Kummer et al | 1995 | Stroke | Prospective cohort | No <360 min | ICA, M1, M2 | DSA | Immediately post-rtPA | 19 | 61 |
Sasaki et al | 1996 | AJNR | Prospective cohort | No <480 min | M1, M2 | DSA | 24 h | 1 | 3 |
Mori et al | 1992 | Neurology | RCT | No <360 min | ICA, M1, M2, AM | DSA | Immediately post-rtPA | 9 | 19 |
Note:—Recan. indicates recanalization, JNNP, J Neurol Neurosurg Psychiatry; RCT, randomized controlled trial; NRCT, non-randomized controlled trial; CTA, CT angiography; DSA, digital subtraction angiography; MRA, MR angiography; TCD, transcranial Doppler sonography; ICA, internal carotid artery; ACA, anterior cerebral artery; MCA, middle cerebral artery; M1, M1 branch of the MCA; M2, M2 branch of the MCA; M3, M3 branch of the MCA; AM, A2 branch of the ACA; NS, not specified; rtPA, recombinant tissue plasminogen activator; DIAS I, Desmoteplase in Acute Ishemic Stroke Trial; NINDS, National Institute of Neurological Disorders and Stroke.
Included are data indicating whether rtPA was administered as per the protocol used in the NINDS trial.24
All studies are listed in on-line Fig 1.